(Q79931397)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Historical control study of paclitaxel-carboplatin (TJ) versus conventional platinum-based chemotherapy (CAP) for epithelial ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

Reiko Numazaki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Etsuko Miyagi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Ryo Onose

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Tsuneo Nakazawa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Ken Sugiura

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Kunio Asukai

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Hiroki Nakayama

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Atsushi Miyamatsu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Naoyuki Okamoto

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Fumiki Hirahara

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850129%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Clinical Oncology

27 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

221-228

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850129%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10147-005-0555-0

27 December 2019

exact match

0 references

cites work

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

1 reference

12 December 2020

Weekly and monthly regimens of paclitaxel and carboplatin in the management of advanced ovarian cancer. A preliminary report on side effects

1 reference

12 December 2020

Clinical trials of newer regimens for treating ovarian cancer: the rationale for Gynecologic Oncology Group Protocol GOG 182-ICON5.

1 reference

12 December 2020

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

12 December 2020

First-line chemotherapy with weekly paclitaxel and carboplatin for advanced ovarian cancer: a phase I study

1 reference

12 December 2020

Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy

1 reference

12 December 2020

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

1 reference

12 December 2020

[A case of clear cell carcinoma of the ovary responding to a paclitaxel-carboplatin combination chemotherapy]

1 reference

12 December 2020

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

12 December 2020

Developmental chemotherapy in advanced ovarian cancer: incorporation of newer cytotoxic agents in a phase III randomized trial of the Gynecologic Oncology Group (GOG-0182).

1 reference

12 December 2020

Clear clinical remission of a diffuse metastasized ovarian clear cell carcinoma with third line chemotherapy

1 reference

12 December 2020

Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience

1 reference

12 December 2020

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

1 reference

12 December 2020

Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer.

1 reference

12 December 2020

Outpatient taxol and carboplatin chemotherapy for suboptimally debulked epithelial carcinoma of the ovary results in improved quality of life: an Eastern Cooperative Oncology Group Phase II Study (E2E93).

1 reference

12 December 2020

10.1007/S10147-005-0555-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference